Logo image of ERA.PA

ERAMET (ERA.PA) Stock Fundamental Analysis

EPA:ERA - Euronext Paris - Matif - FR0000131757 - Common Stock - Currency: EUR

50.7  +0.92 (+1.85%)

Fundamental Rating

3

ERA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 37 industry peers in the Metals & Mining industry. ERA has a medium profitability rating, but doesn't score so well on its financial health evaluation. ERA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year ERA was profitable.
In the past year ERA has reported a negative cash flow from operations.
Of the past 5 years ERA 4 years were profitable.
Of the past 5 years ERA 4 years had a positive operating cash flow.
ERA.PA Yearly Net Income VS EBIT VS OCF VS FCFERA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

ERA has a Return On Assets (0.22%) which is in line with its industry peers.
ERA has a Return On Equity (0.97%) which is comparable to the rest of the industry.
ERA has a Return On Invested Capital of 1.39%. This is in the lower half of the industry: ERA underperforms 62.16% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ERA is in line with the industry average of 6.20%.
The 3 year average ROIC (7.61%) for ERA is well above the current ROIC(1.39%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.22%
ROE 0.97%
ROIC 1.39%
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ERA.PA Yearly ROA, ROE, ROICERA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

ERA has a Profit Margin of 0.48%. This is comparable to the rest of the industry: ERA outperforms 40.54% of its industry peers.
In the last couple of years the Profit Margin of ERA has declined.
ERA has a Operating Margin (3.27%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ERA has declined.
ERA has a better Gross Margin (66.89%) than 89.19% of its industry peers.
In the last couple of years the Gross Margin of ERA has grown nicely.
Industry RankSector Rank
OM 3.27%
PM (TTM) 0.48%
GM 66.89%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
ERA.PA Yearly Profit, Operating, Gross MarginsERA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

ERA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ERA has been increased compared to 1 year ago.
The number of shares outstanding for ERA has been increased compared to 5 years ago.
ERA has a better debt/assets ratio than last year.
ERA.PA Yearly Shares OutstandingERA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ERA.PA Yearly Total Debt VS Total AssetsERA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.13, we must say that ERA is in the distress zone and has some risk of bankruptcy.
ERA's Altman-Z score of 1.13 is on the low side compared to the rest of the industry. ERA is outperformed by 81.08% of its industry peers.
A Debt/Equity ratio of 1.35 is on the high side and indicates that ERA has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.35, ERA is doing worse than 83.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Altman-Z 1.13
ROIC/WACC0.15
WACC9.3%
ERA.PA Yearly LT Debt VS Equity VS FCFERA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 1.64 indicates that ERA should not have too much problems paying its short term obligations.
ERA has a Current ratio of 1.64. This is comparable to the rest of the industry: ERA outperforms 48.65% of its industry peers.
A Quick Ratio of 1.17 indicates that ERA should not have too much problems paying its short term obligations.
ERA has a better Quick ratio (1.17) than 72.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.17
ERA.PA Yearly Current Assets VS Current LiabilitesERA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

3

3. Growth

3.1 Past

ERA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.47%.
The earnings per share for ERA have been decreasing by -64.00% on average. This is quite bad
The Revenue has decreased by -9.78% in the past year.
ERA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.39% yearly.
EPS 1Y (TTM)-88.47%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%406.32%
Revenue 1Y (TTM)-9.78%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-10.08%

3.2 Future

ERA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.30% yearly.
Based on estimates for the next years, ERA will show a small growth in Revenue. The Revenue will grow by 7.26% on average per year.
EPS Next Y-57.76%
EPS Next 2Y8.24%
EPS Next 3Y31.3%
EPS Next 5YN/A
Revenue Next Year5.81%
Revenue Next 2Y7.34%
Revenue Next 3Y7.26%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ERA.PA Yearly Revenue VS EstimatesERA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
ERA.PA Yearly EPS VS EstimatesERA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 117.91 indicates a quite expensive valuation of ERA.
Compared to the rest of the industry, the Price/Earnings ratio of ERA indicates a slightly more expensive valuation: ERA is more expensive than 62.16% of the companies listed in the same industry.
ERA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.99.
With a Price/Forward Earnings ratio of 28.60, ERA can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ERA indicates a slightly more expensive valuation: ERA is more expensive than 70.27% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.35, ERA is valued a bit more expensive.
Industry RankSector Rank
PE 117.91
Fwd PE 28.6
ERA.PA Price Earnings VS Forward Price EarningsERA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ERA is valued a bit more expensive than the industry average as 62.16% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.69
ERA.PA Per share dataERA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80 100

4.3 Compensation for Growth

ERA's earnings are expected to grow with 31.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.24%
EPS Next 3Y31.3%

More info and screens

3

5. Dividend

5.1 Amount

ERA has a Yearly Dividend Yield of 3.09%. Purely for dividend investing, there may be better candidates out there.
ERA's Dividend Yield is a higher than the industry average which is at 3.85.
Compared to an average S&P500 Dividend Yield of 2.44, ERA pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.09%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
ERA.PA Yearly Dividends per shareERA.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 2025 1 2 3

5.3 Sustainability

ERA pays out 307.14% of its income as dividend. This is not a sustainable payout ratio.
DP307.14%
EPS Next 2Y8.24%
EPS Next 3Y31.3%
ERA.PA Yearly Income VS Free CF VS DividendERA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M
ERA.PA Dividend Payout.ERA.PA Dividend Payout, showing the Payout Ratio.ERA.PA Dividend Payout.PayoutRetained Earnings

More info and screens

ERAMET

EPA:ERA (5/8/2025, 5:29:01 PM)

50.7

+0.92 (+1.85%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-24 2025-04-24
Earnings (Next)07-23 2025-07-23
Inst Owners11.15%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap1.46B
Analysts76
Price Target72.25 (42.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.09%
Yearly Dividend1.51
Dividend Growth(5Y)N/A
DP307.14%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-15%
PT rev (3m)-15.17%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-39.06%
EPS NY rev (3m)-73.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.22%
Revenue NY rev (3m)-4.93%
Valuation
Industry RankSector Rank
PE 117.91
Fwd PE 28.6
P/S 0.5
P/FCF N/A
P/OCF N/A
P/B 1.01
P/tB 1.45
EV/EBITDA 9.69
EPS(TTM)0.43
EY0.85%
EPS(NY)1.77
Fwd EY3.5%
FCF(TTM)-28.23
FCFYN/A
OCF(TTM)-4.35
OCFYN/A
SpS101.98
BVpS50.1
TBVpS34.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.22%
ROE 0.97%
ROCE 1.92%
ROIC 1.39%
ROICexc 1.7%
ROICexgc 1.9%
OM 3.27%
PM (TTM) 0.48%
GM 66.89%
FCFM N/A
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ROICexc(3y)11.46%
ROICexc(5y)11.88%
ROICexgc(3y)13.48%
ROICexgc(5y)14.02%
ROCE(3y)10.76%
ROCE(5y)11.32%
ROICexcg growth 3Y-56.22%
ROICexcg growth 5Y-25.38%
ROICexc growth 3Y-55.33%
ROICexc growth 5Y-24.94%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
F-Score2
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Debt/EBITDA 7.9
Cap/Depr 454.97%
Cap/Sales 23.42%
Interest Coverage 0.56
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.17
Altman-Z 1.13
F-Score2
WACC9.3%
ROIC/WACC0.15
Cap/Depr(3y)260.42%
Cap/Depr(5y)209.27%
Cap/Sales(3y)18.57%
Cap/Sales(5y)15.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.47%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%406.32%
EPS Next Y-57.76%
EPS Next 2Y8.24%
EPS Next 3Y31.3%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.78%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-10.08%
Revenue Next Year5.81%
Revenue Next 2Y7.34%
Revenue Next 3Y7.26%
Revenue Next 5YN/A
EBIT growth 1Y-23.81%
EBIT growth 3Y-50.34%
EBIT growth 5Y-22.39%
EBIT Next Year127.39%
EBIT Next 3Y42.35%
EBIT Next 5YN/A
FCF growth 1Y-61.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-161.27%
OCF growth 3YN/A
OCF growth 5YN/A